Somaxon Pharmaceuticals, Inc Merger Litigation (Nasdaq: SOMX)

Law Office of Brodsky & Smith, LLC Announces Investigation of Somaxon Pharmaceuticals, Inc. 
 
BALA CYNWYD, December 13, 2012/PR Newswire/ –Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Somaxon , Inc. (“Somaxon” or the “Company”) (Nasdaq- SOMX-News) relating to the proposed acquisition by Pernix Therapeutics Holdings, Inc. (“Pernix”).  
 
Under the terms of the transaction, Somaxon shareholders will receive only $25 million in Pernix common stock. The number of Pernix stock issued will be based on the volume-weighted average price of Pernix’s common stock in the 30 day period prior to the merger closing, representing a value of between $6.00 and $9.00 per Somaxon share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Somaxon for not acting in the Company’s shareholders' best interests in connection with the sale process to Pernix.  
 
The transaction may undervalue the Company and will result in a loss for many shareholders. For example Somaxon stock traded at $27.28 as recently as January 6, 2011. In addition, in the 12 months ended September 30, 2012, Somaxon had net sales related to Silenor, a drug approved to treat insomnia, of approximately $11.7 million. Silenor has potential to produce additional revenue as an over-the-counter product in the future. 
 
If you own shares of Somaxon stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com by calling toll free 877-LEGAL-90. 

To Join the Somaxon Pharmaceuticals, Inc Litigation

1. Fill out this form

   Mr/Mrs/Ms --Select a title-- Mr. Mrs. Ms.

   First Name: Required

   Last Name:Required

   
   

   Address: Required

   City: Required

   State: Required Select a State AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY

   
   

   Email Address:Required

   Phone Number:Required

   
   

   Number of Shares Owned:Required

   Date purchased:

   
   

   By clicking on the submit button, I acknowledge that I have downloaded and read both the Merger Class Action Lawsuit Retainer Agreement and Class Representative Rights and Responsibilities documents, and agree to retain Brodsky & Smith, LLC to file an action against Somaxon Pharmaceuticals, Inc in connection with this case. Brodsky & Smith, LLC will prosecute the action on a contingent fee basis and will advance all costs and expenses.
   

View Complaint

The complaint is unavailable at this time

Join Other Cases

Frequently Asked Questions

 

Home : All cases : Report a Fraud

FAQ's : Attorneys : Practice Areas : Contact Us : Links : Disclaimer